These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 11271407)

  • 21. Comparison of the effects of cocaine and its metabolites on cardiovascular function in anesthetized rats.
    Erzouki HK; Baum I; Goldberg SR; Schindler CW
    J Cardiovasc Pharmacol; 1993 Oct; 22(4):557-63. PubMed ID: 7505357
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Within-subject variability in cocaine pharmacokinetics and pharmacodynamics after intraperitoneal compared with intravenous cocaine administration.
    Ma F; Falk JL; Lau CE
    Exp Clin Psychopharmacol; 1999 Feb; 7(1):3-12. PubMed ID: 10036604
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Direct approach for attenuating cocaine's effects on extracellular dopamine: targeting the dopamine transporter.
    Morgan AE; Porter SP; Clarkson FA; Volkow ND; Fowler JS; Dewey SL
    Synapse; 1997 Aug; 26(4):423-7. PubMed ID: 9215601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acquisition of cocaine self-administration in male Sprague-Dawley rats: effects of cocaine dose but not initial locomotor response to cocaine.
    Mandt BH; Johnston NL; Zahniser NR; Allen RM
    Psychopharmacology (Berl); 2012 Feb; 219(4):1089-97. PubMed ID: 21863236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Repeated administration of the D1/5 antagonist ecopipam fails to attenuate the subjective effects of cocaine.
    Nann-Vernotica E; Donny EC; Bigelow GE; Walsh SL
    Psychopharmacology (Berl); 2001 Jun; 155(4):338-47. PubMed ID: 11441423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopaminergic antagonism within the nucleus accumbens or the amygdala produces differential effects on intravenous cocaine self-administration under fixed and progressive ratio schedules of reinforcement.
    McGregor A; Roberts DC
    Brain Res; 1993 Oct; 624(1-2):245-52. PubMed ID: 8252397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cocaine and alcohol interactions in the rat: contribution of cocaine metabolites to the pharmacological effects.
    Pan WJ; Hedaya MA
    J Pharm Sci; 1999 Apr; 88(4):468-76. PubMed ID: 10187759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sensitization of operant behavior to oral cocaine with increasing- and repetitive-dose regimens.
    Lobarinas E; Lau CE; Falk JL
    Behav Pharmacol; 1999 Feb; 10(1):15-26. PubMed ID: 10780299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ethanol effects on self-administration of alfentanil, cocaine, and nomifensine in rhesus monkeys.
    Aspen JM; Winger G
    Psychopharmacology (Berl); 1997 Apr; 130(3):222-7. PubMed ID: 9151355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The novel dopamine D3 receptor antagonist NGB 2904 inhibits cocaine's rewarding effects and cocaine-induced reinstatement of drug-seeking behavior in rats.
    Xi ZX; Newman AH; Gilbert JG; Pak AC; Peng XQ; Ashby CR; Gitajn L; Gardner EL
    Neuropsychopharmacology; 2006 Jul; 31(7):1393-405. PubMed ID: 16205781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rats choose cocaine over dopamine agonists in a two-lever self-administration preference test.
    Manzardo AM; Del Rio JA; Stein L; Belluzzi JD
    Pharmacol Biochem Behav; 2001; 70(2-3):257-65. PubMed ID: 11701196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Norcocaine is a potent modulator of haemodynamic responses, plasma catecholamines and cardiac hormone release in conscious rats.
    Mahlakaarto J; Ruskoaho H; Huttunen P; MacDonald E; Pasanen M
    Toxicology; 1998 Jul; 128(2):101-11. PubMed ID: 9710151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for opponent-process actions of intravenous cocaine.
    Ettenberg A; Raven MA; Danluck DA; Necessary BD
    Pharmacol Biochem Behav; 1999 Nov; 64(3):507-12. PubMed ID: 10548263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low and high locomotor responsiveness to cocaine predicts intravenous cocaine conditioned place preference in male Sprague-Dawley rats.
    Allen RM; Everett CV; Nelson AM; Gulley JM; Zahniser NR
    Pharmacol Biochem Behav; 2007 Jan; 86(1):37-44. PubMed ID: 17250883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dextromethorphan alters the reinforcing effect of cocaine in the rat.
    Kim HC; Park BK; Hong SY; Jhoo WK
    Methods Find Exp Clin Pharmacol; 1997 Nov; 19(9):627-31. PubMed ID: 9500126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential blockade of chronic versus acute effects of intravenous cocaine by dopamine receptor antagonists.
    Tella SR
    Pharmacol Biochem Behav; 1994 May; 48(1):151-9. PubMed ID: 8029285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cocaine's time action profile on regional cerebral blood flow in the rat.
    Stein EA; Fuller SA
    Brain Res; 1993 Oct; 626(1-2):117-26. PubMed ID: 8281422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of peripheral and central sodium channels in mediating brain temperature fluctuations induced by intravenous cocaine.
    Kiyatkin EA; Brown PL
    Brain Res; 2006 Oct; 1117(1):38-53. PubMed ID: 16956595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amphetamine maintenance therapy during intermittent cocaine self-administration in rats attenuates psychomotor and dopamine sensitization and reduces addiction-like behavior.
    Allain F; Delignat-Lavaud B; Beaudoin MP; Jacquemet V; Robinson TE; Trudeau LE; Samaha AN
    Neuropsychopharmacology; 2021 Jan; 46(2):305-315. PubMed ID: 32682325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CGP 44532, a GABAB receptor agonist, is hedonically neutral and reduces cocaine-induced enhancement of reward.
    Dobrovitsky V; Pimentel P; Duarte A; Froestl W; Stellar JR; Trzcińska M
    Neuropharmacology; 2002 Apr; 42(5):626-32. PubMed ID: 11985820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.